find a clinical trial
If you have any questions or are interested in participating in one of our Clinical Trials, please take note of the associated protocol number and contact our team at 201-518-3587, or email us.
59
Clinical Trials
Lymphoma
N/A
Enrolling
Lymphoma
N/A
Enrolling
nct/study# N/A / 00004434
Retrospective examination of outcomes in patients with “Double-Hit” Lymphoma
Learn More
Lymphoma
Phase I/II
Enrolling
nct/study# NCT03331198 / 017004
An Open-Label, Phase 1/2 Study of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (017004)
Learn More
Lymphoma
N/A
Enrolling
nct/study# N/A / 00003859
Mantle Cell Lymphoma Immunohistochemistry and Risk Factor Analysis
Learn More
Lymphoma
Phase II
Enrolling
nct/study# NCT05910801 / ACCRU-LY-2101
Tafasitamab, Lenalidomide and Venetoclax Combination Therapy for Relapsed or Refractory Mantle Cell Lymphoma (V-MIND): A Phase II Study with Safety Lead-in
Learn More
Lymphoma
N/A
Enrolling
nct/study# NCT06500273 / ALLO-501A-202
A randomized, open-label study evaluating the efficacy and safety of cemacabtagene ansegedleucel in participants with minimal residual disease after response to first line therapy for large B-cell lymphoma ALPHA3)
Learn Morewe are here for you
For more information or to schedule an appointment,
call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.